Free Trial

Aurora Cannabis (TSE:ACB) Stock Price Down 0.8% - Time to Sell?

Aurora Cannabis logo with Medical background

Shares of Aurora Cannabis Inc. (TSE:ACB - Get Free Report) dropped 0.8% on Thursday . The stock traded as low as C$6.26 and last traded at C$6.34. Approximately 62,609 shares traded hands during trading, a decline of 84% from the average daily volume of 389,808 shares. The stock had previously closed at C$6.39.

Analysts Set New Price Targets

Several equities analysts have commented on the company. ATB Capital dropped their target price on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th. TD Securities upgraded shares of Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th. Three equities research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Aurora Cannabis currently has an average rating of "Moderate Buy" and an average price target of C$5.85.

Get Our Latest Research Report on Aurora Cannabis

Aurora Cannabis Trading Down 6.2 %

The stock has a market capitalization of C$325.23 million, a PE ratio of -9.44 and a beta of 2.71. The stock's 50 day simple moving average is C$6.40 and its two-hundred day simple moving average is C$7.37. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.

Featured Articles

Should You Invest $1,000 in Aurora Cannabis Right Now?

Before you consider Aurora Cannabis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.

While Aurora Cannabis currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

NVIDIA Unveils Game-Changing Tech, But Stock Dips
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines